| Literature DB >> 35629208 |
Jong-Seop Koo1, So Young Kim2.
Abstract
This study aimed to explore the relationship between body mass index (BMI) and hearing loss. We analyzed data from the Korean National Health Insurance Service Health Screening Cohort 2009-2019 (291,471 patients with hearing loss and 6,088,979 control participants). Both patient groups were subsequently divided into four groups according to BMI: <18.5 (underweight), 18.5-24.9 (normal), 25-29.9 (obese I), and ≥30 (obese II). To evaluate the relationship between BMI and hearing loss, multivariate logistic regression analysis was used, adjusting for age, sex, smoking, alcohol consumption, blood pressure, triglycerides, total cholesterol, low-density lipoprotein, proteinuria, serum creatinine, aspartate aminotransferase, alanine aminotransferase, and fasting glucose levels. The adjusted odds ratio (OR) of the underweight group for hearing loss was 1.21 (95% CI = 1.19-1.24) compared to the normal BMI group, whereas the adjusted ORs of obese I and obese II groups for hearing loss were 0.95 and 0.87, respectively. Being underweight was generally associated with an increased prevalence of hearing loss in the Korean adult population.Entities:
Keywords: age; body mass index (BMI); hearing; obesity; sex; underweight
Year: 2022 PMID: 35629208 PMCID: PMC9147342 DOI: 10.3390/jpm12050786
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Figure 1A schematic illustration of the participant selection process used in the present study.
General Characteristics of Participants. BMI, body mass index; LDL, low-density lipoprotein. * Chi-square test. Significance at p-value < 0.05.
| Characteristics | Total Participants | Characteristics | Total Participants | ||||
|---|---|---|---|---|---|---|---|
| Hearing Loss ( | Control | Hearing Loss ( | Control | ||||
| Age (years old) | <0.001 * | Blood pressure | <0.001 * | ||||
| 40–44 | 9817 (3.4) | 743,665 (12.2) | Normal | 175,078 (60.1) | 3,055,041 (50.2) | ||
| 45–49 | 12,762 (7.8) | 721,063 (11.8) | Hypertension | 116,393 (39.9) | 3,033,938 (49.8) | ||
| 50–54 | 22,630 (7.1) | 874,311 (14.4) | Triglyceride (≥200) | 0.489 | |||
| 55–59 | 20,687 (7.1) | 649,950 (10.7) | Yes | 38,159 (13.1) | 794,466 (13.0) | ||
| 60–64 | 30,496 (10.5) | 821,826 (13.5) | No | 253,312 (86.9) | 5,294,513 (87.0) | ||
| 65–69 | 28,241 (9.7) | 576,966 (9.5) | LDL (≥130) | 0.757 | |||
| 70–74 | 40,639 (13.9) | 598,335 (9.8) | Yes | 88,427 (30.3) | 1,848,939 (30.4) | ||
| 75–79 | 29,262 (10.0) | 390,729 (6.4) | No | 203,044 (69.7) | 4,240,040 (69.6) | ||
| 80+ | 96,937 (33.3) | 712,134 (11.7) | Total | <0.001 * | |||
| Yes | 120,856 (41.5) | 2,643,014 (43.4) | |||||
| Sex | <0.001 * | No | 170,615(58.5) | 3,445,965 (56.6) | |||
| Male | 158,741 (54.5) | 3,148,677 (51.7) | Proteinuria | <0.001 * | |||
| Female | 132,730 (45.5) | 2,940,302 (48.3) | Abnormal | 8968 (3.1) | 128,000 (2.1) | ||
| Smoking | <0.001 * | Normal | 282,503(96.9) | 5,960,979 (97.9) | |||
| No | 183,935 (63.1) | 3,767,870 (61.9) | Creatinine (≥1.4) | <0.001 * | |||
| Past | 59,447 (20.4) | 1,078,171 (17.7) | Yes | 5195 (1.8) | 40,668 (0.7) | ||
| Active | 48,089 (16.5) | 1,242,938 (20.4) | No | 286,276 (98.2) | 6,048,311 (99.3) | ||
| Alcohol consumption | <0.001 * | AST (>40) | <0.001 * | ||||
| Yes | 132,257 (45.5) | 2,969,941 (48.8) | Yes | 17,431 (6.0) | 305,759 (5.1) | ||
| No | 159,214 (54.6) | 3,119,038 (51.2) | No | 274,040 (94.0) | 5,783,220 (95.0) | ||
| BMI | ALT (>40) | ||||||
| <18.5 | 11,143 (3.8) | 221,279 (3.6) | Yes | 22,935 (7.9) | 578,965 (9.5) | ||
| 18.5~24.9 | 185,217 (63.5) | 3,945,739 (64.8) | No | 268,536 (9.5) | 5,510,014 (90.5) | ||
| 25~29.9 | 86,393 (29.6) | 1,720,321 (28.3) | Fasting | <0.001 * | |||
| ≥30 | 8718 (3.0) | 201,640 (3.3) | Yes | 115,459 (39.6) | 1,905,076 (31.3) | ||
| No | 176,012 (60.4) | 4,183,903 (68.7) | |||||
Crude and adjusted odds ratios (95% confidence interval) of BMI, Triglyceride, and LDL for hearing loss. * Multiple logistic regression model, Significance at p < 0.05. † Adjusted model for age, sex, smoking, alcohol consumption, blood pressure, triglycerides, total cholesterol, LDL, proteinuria, serum creatinine, AST, ALT, and fasting glucose levels, Significance at p < 0.05.
| Characteristics | Odds Ratio (95% CI) | |||
|---|---|---|---|---|
| Crude | Adjusted † | |||
| BMI (kg/m2) | <0.001 * | <0.001 † | ||
| <18.5 ( | 1.073 (1.052–1.094) | <0.001 * | 1.213 (1.189–1.238) | <0.001 † |
| 18.5~24.9 ( | 1.00 | 1.00 | ||
| 25~29.9 ( | 1.070 (1.061–1.079) | <0.001 * | 0.954 (0.946–0.962) | <0.001 † |
| ≥30 ( | 0.921 (0.901–0.941) | <0.001 * | 0.873 (0.854–0.893) | <0.001 † |
| Triglyceride ≥ 200 mg/dL | 0.480 | <0.001 † | ||
| Yes ( | 1.004 (0.993–1.015) | 0.480 | 1.017 (1.006–1.029) | <0.004 † |
| No ( | 1.00 | 1.00 | ||
| LDL ≥ 130 mg/dL | 0.755 | <0.001 † | ||
| Yes ( | 0.999 (0.991–1.007) | 0.755 | 1.084 (1.071–1.097) | <0.001 † |
| No ( | 1.00 | 1.00 | ||
Subgroup analysis of crude and adjusted odds ratio (95% confidence interval) of BMI for hearing loss according to age. * Multiple logistic regression model, Significance at p < 0.05. † Adjusted model for sex, smoking, alcohol consumption, blood pressure, LDL, triglyceride, total cholesterol, proteinuria, serum creatinine, AST, ALT, fasting glucose, Significance at p < 0.05.
| Characteristics | Odds Ratio (95% CI) | |||
|---|---|---|---|---|
| Crude | Adjusted † | |||
| Male, 40–59 years old, | ||||
| BMI (kg/m2) | <0.001 * | <0.001 † | ||
| <18.5 ( | 1.258 (1.185–1.335) | <0.001 * | 1.340 (1.262–1.423) | <0.001 † |
| 18.5~24.9 ( | 1.00 | 1.00 | ||
| 25~29.9 ( | 0.954 (0.934–0.975) | <0.001 * | 0.909 (0.889–0.930) | <0.001 † |
| ≥30 ( | 0.657 (0.615–0.702) | <0.001* | 0.627 (0.586–0.670) | <0.001 † |
| Male, 60–79 years old, | ||||
| BMI (kg/m2) | <0.001 * | <0.001 † | ||
| <18.5 ( | 1.645 (1.580–1.713) | <0.001 * | 1.582 (1.519–1.648) | <0.001 † |
| 18.5~24.9 ( | 1.00 | 1.00 | ||
| 25~29.9 ( | 0.843 (0.829–0.857) | <0.001 * | 0.858 (0.843–0.872) | <0.001 † |
| ≥30 ( | 0.547 (0.516–0.580) | <0.001 * | 0.603 (0.568–0.639) | <0.001 † |
| Male, +80 years old, | ||||
| BMI (kg/m2) | <0.001 * | <0.001 † | ||
| <18.5 ( | 1.351 (1.288–1.417) | <0.001 * | 1.201 (1.144–1.262) | <0.001 † |
| 18.5~24.9 ( | 1.00 | 1.00 | ||
| 25~29.9 ( | 0.859 (0.841–0.876) | <0.001 * | 0.915 (0.895–0.934) | <0.001 † |
| ≥30 ( | 0.817 (0.759–0.879) | <0.001 * | 0.922 (0.856–0.994) | 0.034 † |
| Female, 40 – 59 years old, | ||||
| BMI (kg/m2) | <0.001 * | <0.001 † | ||
| <18.5 ( | 0.590 (0.553–0.629) | <0.001 * | 0.691 (0.647–0.737) | <0.001 † |
| 18.5~24.9 ( | 1.00 | 1.00 | ||
| 25~29.9 ( | 1.272 (1.234–1.311) | <0.001 * | 1.105 (1.071–1.140) | <0.001 † |
| ≥30 ( | 1.338 (1.254–1.427) | <0.001 * | 1.110 (1.039–1.186) | 0.002 † |
| Female, 60 – 79 years old, | ||||
| BMI (kg/m2) | <0.001 * | <0.001 † | ||
| <18.5 ( | 0.970 (0.927–1.015) | 0.184 | 1.061 (1.013–1.110) | 0.011 † |
| 18.5~24.9 ( | 1.00 | 1.00 | ||
| 25~29.9 ( | 1.235 (1.212–1.258) | <0.001 * | 1.105 (1.084–1.126) | <0.001 † |
| ≥30 ( | 1.209 (1.161–1.259) | <0.001 * | 1.047 (1.005–1.092) | 0.029 † |
| Female, +80 years old, | ||||
| BMI (kg/m2) | <0.001 * | <0.001 † | ||
| <18.5 ( | 1.533 (1.459–1.611) | <0.001 * | 1.309 (1.244–1.378) | <0.001 † |
| 18.5~24.9 ( | 1.00 | 1.00 | ||
| 25~29.9 ( | 1.010 (0.989–1.032) | 0.345 | 1.003 (0.981–1.025) | 0.812 |
| ≥30 ( | 1.017 (0.971–1.066) | 0.471 | 0.985 (0.939–1.033) | 0.525 |